MedTrace Logo

Assessment of Growth of Infants Fed a New Formula

NCT00937014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2013-06-26

No results posted yet for this study

Summary

The purpose of this clinical trial is to assess growth (rate of weight gain in grams per day) of infants fed an infant formula with a whey isolate enriched with lactoferrin, during the first four months of life as compared to infants fed a standard infant formula.

Conditions

  • Infant Nutrition

Interventions

OTHER

standard infant formula

Standard infant formula given during the first 9 months of life, as per standard requirement

OTHER

Test formula

Test formula enriched in lactoferrin given during the first 9 months of life, as per standard requirement.

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Susan Feigelman, MD · University of Maryland School of Medicine, Department of Pediatrics

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
11 Days
Max Age
17 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00937014 on ClinicalTrials.gov